These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 28049580)
41. Integrated microRNA-mRNA analysis of pancreatic ductal adenocarcinoma. Liu PF; Jiang WH; Han YT; He LF; Zhang HL; Ren H Genet Mol Res; 2015 Aug; 14(3):10288-97. PubMed ID: 26345967 [TBL] [Abstract][Full Text] [Related]
42. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer. Ye S; Yang L; Zhao X; Song W; Wang W; Zheng S Cell Biochem Biophys; 2014 Dec; 70(3):1849-58. PubMed ID: 25087086 [TBL] [Abstract][Full Text] [Related]
43. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. Cho WC; Chow AS; Au JS Eur J Cancer; 2009 Aug; 45(12):2197-206. PubMed ID: 19493678 [TBL] [Abstract][Full Text] [Related]
44. Microarray analysis of differentially expressed microRNAs in allergic rhinitis. Shaoqing Y; Ruxin Z; Guojun L; Zhiqiang Y; Hua H; Shudong Y; Jie Z Am J Rhinol Allergy; 2011; 25(6):e242-6. PubMed ID: 22185732 [TBL] [Abstract][Full Text] [Related]
45. Expression analysis of miRNA and target mRNAs in esophageal cancer. Meng XR; Lu P; Mei JZ; Liu GJ; Fan QX Braz J Med Biol Res; 2014 Sep; 47(9):811-7. PubMed ID: 25098614 [TBL] [Abstract][Full Text] [Related]
46. Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young women. Oltra SS; Peña-Chilet M; Vidal-Tomas V; Flower K; Martinez MT; Alonso E; Burgues O; Lluch A; Flanagan JM; Ribas G Sci Rep; 2018 Sep; 8(1):14373. PubMed ID: 30258192 [TBL] [Abstract][Full Text] [Related]
47. Shared genetic and epigenetic mechanisms between chronic periodontitis and oral squamous cell carcinoma. Li S; Liu X; Zhou Y; Acharya A; Savkovic V; Xu C; Wu N; Deng Y; Hu X; Li H; Haak R; Schmidt J; Shang W; Pan H; Shang R; Yu Y; Ziebolz D; Schmalz G Oral Oncol; 2018 Nov; 86():216-224. PubMed ID: 30409304 [TBL] [Abstract][Full Text] [Related]
48. A Five-microRNA Signature for Survival Prognosis in Pancreatic Adenocarcinoma based on TCGA Data. Shi XH; Li X; Zhang H; He RZ; Zhao Y; Zhou M; Pan ST; Zhao CL; Feng YC; Wang M; Guo XJ; Qin RY Sci Rep; 2018 May; 8(1):7638. PubMed ID: 29769534 [TBL] [Abstract][Full Text] [Related]
49. Uncovering the potential miRNAs and mRNAs in follicular variant of papillary thyroid carcinoma in the Cancer Genome Atlas database. Li M; Zhao B; Qu W; Zhang Z; Jiang Z Transl Cancer Res; 2019 Aug; 8(4):1158-1169. PubMed ID: 35116858 [TBL] [Abstract][Full Text] [Related]
50. Primary analysis and screening of microRNAs in gastric cancer side population cells. Zhang HH; Gu GL; Zhang XY; Li FZ; Ding L; Fan Q; Wu R; Shi W; Wang XY; Chen L; Wei XM; Yuan XY World J Gastroenterol; 2015 Mar; 21(12):3519-26. PubMed ID: 25834316 [TBL] [Abstract][Full Text] [Related]
51. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer. Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472 [TBL] [Abstract][Full Text] [Related]
52. The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma. He XX; Kuang SZ; Liao JZ; Xu CR; Chang Y; Wu YL; Gong J; Tian DA; Guo AY; Lin JS Mol Biosyst; 2015 Feb; 11(2):532-9. PubMed ID: 25424171 [TBL] [Abstract][Full Text] [Related]
53. Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits. Pal B; Chen Y; Bert A; Hu Y; Sheridan JM; Beck T; Shi W; Satterley K; Jamieson P; Goodall GJ; Lindeman GJ; Smyth GK; Visvader JE Breast Cancer Res; 2015 Jun; 17(1):85. PubMed ID: 26080807 [TBL] [Abstract][Full Text] [Related]
54. Genetic analyses of differences between solid and nonsolid predominant lung adenocarcinomas. Luo J; Ma K; Shi Y; Chen Z; Zhao M; Huang Y; Wang S; Xi J; Zhan C; Xu S; Wang Q Thorac Cancer; 2018 Dec; 9(12):1656-1663. PubMed ID: 30276966 [TBL] [Abstract][Full Text] [Related]
55. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma. Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196 [TBL] [Abstract][Full Text] [Related]
56. Possible tumor suppressive role of the miR-144/451 cluster in esophageal carcinoma as determined by principal component regression analysis. Gao Z; Liu R; Liao J; Yang M; Pan E; Yin L; Pu Y Mol Med Rep; 2016 Oct; 14(4):3805-13. PubMed ID: 27572636 [TBL] [Abstract][Full Text] [Related]
57. Genome-wide expression and methylation profiles reveal candidate genes and biological processes underlying synovial inflammatory tissue of patients with osteoarthritis. Yang J; Wang N Int J Rheum Dis; 2015 Sep; 18(7):783-90. PubMed ID: 26171692 [TBL] [Abstract][Full Text] [Related]
58. Predictive value of MicroRNAs in the progression of barrett esophagus to adenocarcinoma in a long-term follow-up study. Revilla-Nuin B; Parrilla P; Lozano JJ; de Haro LF; Ortiz A; Martínez C; Munitiz V; de Angulo DR; Bermejo J; Molina J; Cayuela ML; Yélamos J Ann Surg; 2013 May; 257(5):886-93. PubMed ID: 23059500 [TBL] [Abstract][Full Text] [Related]
59. Predicting miRNA Association with Corresponding Target Genes and Single Nucleotide Polymorphisms in Altered Renal Pathophysiology. Jaswani P; Prakash S; Agrawal S; Prasad N; Sharma RK Microrna; 2017 Dec; 6(3):213-221. PubMed ID: 29034845 [TBL] [Abstract][Full Text] [Related]